269 related articles for article (PubMed ID: 27252268)
1. Anti-beta-2 glycoprotein I epitope specificity: from experimental models to diagnostic tools.
Meroni PL
Lupus; 2016 Jul; 25(8):905-10. PubMed ID: 27252268
[TBL] [Abstract][Full Text] [Related]
2. New tests to detect antiphospholipid antibodies: anti-domain I beta-2-glycoprotein-I antibodies.
Chighizola CB; Gerosa M; Meroni PL
Curr Rheumatol Rep; 2014 Feb; 16(2):402. PubMed ID: 24390756
[TBL] [Abstract][Full Text] [Related]
3. Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome.
Chighizola CB; Pregnolato F; Andreoli L; Bodio C; Cesana L; Comerio C; Gerosa M; Grossi C; Kumar R; Lazzaroni MG; Mahler M; Mattia E; Nalli C; Norman GL; Raimondo MG; Ruffatti A; Tonello M; Trespidi L; Tincani A; Borghi MO; Meroni PL
J Autoimmun; 2018 Jun; 90():76-83. PubMed ID: 29454510
[TBL] [Abstract][Full Text] [Related]
4. The clinical value of assays detecting antibodies against domain I of β2-glycoprotein I in the antiphospholipid syndrome.
Yin D; de Laat B; Devreese KMJ; Kelchtermans H
Autoimmun Rev; 2018 Dec; 17(12):1210-1218. PubMed ID: 30316989
[TBL] [Abstract][Full Text] [Related]
5. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of anti-domain I-β2Glycoprotein 1 antibodies in antiphospholipid antibody carriers. A single centre, prospective observational follow-up study.
Tonello M; Mattia E; Del Ross T; Favaro M; Calligaro A; Hoxha A; Bison E; Pengo V; Ruffatti A
Clin Chim Acta; 2018 Oct; 485():74-78. PubMed ID: 29953850
[TBL] [Abstract][Full Text] [Related]
7. The IgA Isotype of Anti-β2 Glycoprotein I Antibodies Recognizes Epitopes in Domains 3, 4, and 5 That Are Located in a Lateral Zone of the Molecule (L-Shaped).
Serrano M; Martinez-Flores JA; Norman GL; Naranjo L; Morales JM; Serrano A
Front Immunol; 2019; 10():1031. PubMed ID: 31134087
[No Abstract] [Full Text] [Related]
8. Some antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteases.
Lin WS; Chen PC; Yang CD; Cho E; Hahn BH; Grossman J; Hwang KK; Chen PP
Arthritis Rheum; 2007 May; 56(5):1638-47. PubMed ID: 17469158
[TBL] [Abstract][Full Text] [Related]
9. Domain I of beta2-glycoprotein I: its role as an epitope and the potential to be developed as a specific target for the treatment of the antiphospholipid syndrome.
Ioannou Y; Rahman A
Lupus; 2010 Apr; 19(4):400-5. PubMed ID: 20353977
[TBL] [Abstract][Full Text] [Related]
10. Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation.
Forastiero R
Lupus; 2014 Oct; 23(12):1252-4. PubMed ID: 25228718
[TBL] [Abstract][Full Text] [Related]
11. IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome.
Mattia E; Ruffatti A; Tonello M; Meneghel L; Robecchi B; Pittoni M; Gallo N; Salvan E; Teghil V; Punzi L; Plebani M
Clin Chem Lab Med; 2014 Sep; 52(9):1329-33. PubMed ID: 24651022
[TBL] [Abstract][Full Text] [Related]
12. TLR4 is involved in the pathogenic effects observed in a murine model of antiphospholipid syndrome.
Xie H; Kong X; Zhou H; Xie Y; Sheng L; Wang T; Xia L; Yan J
Clin Immunol; 2015 Oct; 160(2):198-210. PubMed ID: 26065621
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
[TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid syndrome: 30 years and our contribution.
Koike T
Int J Rheum Dis; 2015 Feb; 18(2):233-41. PubMed ID: 25524556
[TBL] [Abstract][Full Text] [Related]
15. Detection of anti-domain I antibodies by chemiluminescence enables the identification of high-risk antiphospholipid syndrome patients: A multicenter multiplatform study.
Yin D; Chayoua W; Kelchtermans H; de Groot PG; Moore GW; Gris JC; Zuily S; Musial J; de Laat B; Devreese KMJ
J Thromb Haemost; 2020 Feb; 18(2):463-478. PubMed ID: 31749277
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance and correlations between anti-β2 glycoprotein I IgA assays in antiphospholipid syndrome and/or systemic lupus erythematosus.
Tebo AE; Willis R; Jaskowski TD; Guerra M; Pierangeli SS; Salmon J; Petri M; Branch DW
Clin Chim Acta; 2016 Sep; 460():107-13. PubMed ID: 27346478
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid antibodies: evaluation of the thrombotic risk.
Devreese KM
Thromb Res; 2012 Oct; 130 Suppl 1():S37-40. PubMed ID: 23026657
[TBL] [Abstract][Full Text] [Related]
18. Novel insights into associations of antibodies against cardiolipin and beta2-glycoprotein I with clinical features of antiphospholipid syndrome.
Shovman O; Gilburd B; Barzilai O; Langevitz P; Shoenfeld Y
Clin Rev Allergy Immunol; 2007 Apr; 32(2):145-52. PubMed ID: 17916984
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG
Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
[TBL] [Abstract][Full Text] [Related]
20. β2-Glycoprotein I-Reactive T Cells in Autoimmune Disease.
Rauch J; Salem D; Subang R; Kuwana M; Levine JS
Front Immunol; 2018; 9():2836. PubMed ID: 30619248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
